Changes in Amino Acid Metabolism of Following Growth to the Stationary Phase Under Adjusted Growth Conditions
Overview
Authors
Affiliations
The sharp increase in infections due to is associated with its ability to adapt to changes in its habitat. This study aimed to investigate the differences in the cytoplasmic amino acid profiles of a clinical strain of under five combinations of stress-induced conditions representative of a wound site by varying temperature 35-37 °C, adding 0-5% NaCl and adjusting pH 6-8. The results indicated that aspartic acid, lysine, glutamic acid and histidine were the most abundant cytoplasmic amino acids in the control samples grown under optimal growth conditions. However, the magnitudes and levels of these amino acids were altered under the various wound site conditions, which led to differential cytoplasmic amino acid profiles as characterized by multivariate analyses (PLS-DA). The total cytoplasmic amino acid content was significantly reduced in the cells grown with 2.5% NaCl added at pH 7 and 37 °C relative to the control samples and other growth regimes. However, all combinations of enhanced stress conditions showed unique and characteristic changes in the concentration profiles of the cytoplasmic amino acids. These outcomes supported the hypothesis that bacterial cells of maintain different metabolic homeostasis under various stress-induced conditions. The potent capability of to constantly and rapidly acclimatize to variations within the environment may reflect the crucial feature supporting its virulence as an opportunistic pathogenic bacterium to invade the wound site. Understanding the control systems governing these marked changes in amino acids during the adaptation to the potential wound site conditions of this dangerous bacterium may offer new clinical controls to combat infection.
Co-culturing with alters transcriptome when exposed to tonsillar cells.
Bastakoti S, Pesonen M, Ajayi C, Julin K, Corander J, Johannessen M Front Cell Infect Microbiol. 2024; 14:1326730.
PMID: 38333035 PMC: 10850355. DOI: 10.3389/fcimb.2024.1326730.
Alreshidi M, Dunstan H, Roberts T, Alreshidi F, Hossain A, Bardakci F Biomol Biomed. 2023; 23(6):1038-1050.
PMID: 37270805 PMC: 10655876. DOI: 10.17305/bb.2023.9246.
Alreshidi M, Dunstan H, MacDonald M, Saeed M, Elkahoui S, Roberts T Microorganisms. 2023; 11(1).
PMID: 36677439 PMC: 9860745. DOI: 10.3390/microorganisms11010147.
Idrees M, Imran M, Atiq N, Zahra R, Abid R, Alreshidi M Front Nutr. 2022; 9:959941.
PMID: 36185680 PMC: 9523698. DOI: 10.3389/fnut.2022.959941.